| ★ | GLP-1 Receptor Agonists Reshape CKD Treatment Sequencing, With Pranav Garimella, MD | | 151 | Estados Unidos | |
| 16 | FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD | | 131 | Estados Unidos | 65 |
| 14 | FIND-CKD Trial Poses Finerenone as a "Third Pillar" for Nondiabetic CKD | | 123 | Estados Unidos | 66 |
| 3 | Sotatercept May Improve RV Function in Group 3 3 Pulmonary Hypertension | | 112 | Estados Unidos | 72 |
| 8 | Improving GLP-1 Adherence in Patients With Diabetes, With Vivian Fonseca, MD | | 91 | Estados Unidos | 67 |
| 6 | SYMPHONY-PE: Early Thrombectomy Improves Pulmonary Embolism Outcomes | | 86 | Estados Unidos | 67 |
| 1 | GLP-1s Move Beyond Diabetes as Core Kidney-Protective Therapy | | 80 | Estados Unidos | 80 |
| 18 | How a Nephrologist Diagnoses and Manages Chronic Kidney Disease | | 70 | Estados Unidos | 65 |
| 19 | Prior Authorization, Precision Medicine, and Eczema Remission, With Jason Hawkes, MD | | 69 | Estados Unidos | 65 |
| 2 | Looking Beyond ALP Response in PBC With Saroglitazar, With Raj Vuppalanchi, MD | | 68 | Estados Unidos | 75 |
| 15 | GLP-1 Discontinuation in Type 2 Diabetes: What Happens When Patients Stop? | | 64 | Estados Unidos | 65 |
| 17 | Improving Heart Failure Care for All, With Joshua Remick, MD | | 59 | Estados Unidos | 65 |
| 5 | Saroglitazar Targets Bile Acid Dysregulation, Inflammation in PBC, With Raj Vuppalanchi, MD | | 55 | Estados Unidos | 68 |
| 20 | Why Does IgA Nephropathy Affect More Men? With Ramy Hanna, MD | | 52 | Estados Unidos | 65 |
| 9 | SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026 | | 48 | Estados Unidos | 67 |
| 7 | Biologic Selection in Severe Asthma: Biomarkers, Comorbidities & Switching Strategies | | 36 | Estados Unidos | 67 |
| 12 | AI-Powered ECG and Echo Could Shrink 2.5-Year Diagnostic Delay in PH | | 31 | Estados Unidos | 66 |
| 10 | Plaque Imaging and the TRANSFORM Trial in Myocardial Infarction | | 29 | Estados Unidos | 66 |
| 4 | B-Cell–Targeted Therapies Expand in IgA Nephropathy, With Samir Parikh, MD | | 27 | Estados Unidos | 71 |
| 11 | Why Quality of Life Can't Take a Back Seat in ISM: Thanai Pongdee, MD, on New PIONEER Data | | 27 | Estados Unidos | 66 |
| 13 | Mitraa-T1D: AI-Driven Converastional Tool Improves T1D Diabetes Distress, Self-Care Behaviors | | 9 | Estados Unidos | 66 |